[Eye toxicity of antimalarial agents].
We relate the evolution of a patient with Systemic Lupus Erythematosus with mucocutaneous, hematological, joint and renal expression. The skin lesions were treated with Chloroquine and Hydroxychloroquine and severe ocular toxicity related with antimalarials agent was developed. We revised the antimalarials use in Rheumatology, their utility, doses, adverse events and risk factors as cumulate doses, ideal daily doses, renal function and ophthalmological reviews recommendations.
Graña Gil
J
J
Servicio de Reumatología, Complejo Hospitalario Juan Canalejo, Xubias de Arriba, 84, 15006 A Coruña.
Cabana Vázquez
M
M
Vázquez González
A
A
Sánchez Meizoso
M O
MO
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*
D000962:Antimalarials; D006886:Hydroxychloroquine; D002738:Chloroquine